Burzynski Research Institute, Inc.
|
-0.01 USD
|
2943.137%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
112.775%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
97.198%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
2264.179%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
1003.427%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
95.126%
|
Qrons Inc.
|
-0.06 USD
|
597.427%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
19433.333%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
604.348%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
3000.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
105.4%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
100.571%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
663.107%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
110.507%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
431.808%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
1323.629%
|
Mesoblast Limited
|
-0.09 USD
|
425.477%
|
Marizyme, Inc.
|
-1.44 USD
|
120.139%
|
Genus plc
|
0.12 USD
|
-141.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
112.446%
|
Pharming Group N.V.
|
-0.02 USD
|
1901.242%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
41528.571%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
169.048%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
400.518%
|
ContraFect Corporation
|
-124.97 USD
|
100.232%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
790.476%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
2516.667%
|
IMV Inc.
|
-4.37 USD
|
106.636%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
919.209%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
290100.0%
|
ONE Bio Corp.
|
1.43 USD
|
79.72%
|
Accustem Sciences Inc.
|
-0.34 USD
|
185.294%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
150.0%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
341.667%
|
Q BioMed Inc.
|
-0.08 USD
|
471.319%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
512.518%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
187.879%
|
Biomind Labs Inc.
|
-0.02 USD
|
1890.123%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
100.037%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
4018.919%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
1557.286%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
12183.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
36350.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
211.538%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
3395.455%
|
GB Sciences, Inc.
|
-0.00 USD
|
7173.171%
|
Alpha Cognition Inc.
|
-0.15 USD
|
293.333%
|
HST Global, Inc.
|
-0.03 USD
|
1139.427%
|
CSL Limited
|
2.73 USD
|
89.377%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
678.842%
|
Halberd Corporation
|
-0.00 USD
|
290100.0%
|
Enzolytics Inc.
|
-0.00 USD
|
41528.571%
|
Agentix Corp.
|
-0.04 USD
|
928.571%
|
Resverlogix Corp.
|
-0.01 USD
|
2142.254%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
484.615%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
-5.16 USD
|
105.62%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
-22207.692%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
-1055.378%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
912.325%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
1550.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
638.033%
|
Zenith Capital Corp.
|
-0.07 USD
|
514.878%
|
Genscript Biotech Corporation
|
-0.05 USD
|
738.767%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
4703.175%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
107.692%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
58100.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
417.634%
|
Kadimastem Ltd
|
-0.78 USD
|
137.179%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
106.17%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
100.797%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
146.774%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
2536.975%
|
LadRx Corporation
|
0.68 USD
|
57.353%
|
Cell Source, Inc.
|
-0.17 USD
|
270.588%
|
Regen BioPharma, Inc.
|
0.26 USD
|
-11.538%
|
NovAccess Global Inc.
|
-0.23 USD
|
226.087%
|
Affymax, Inc.
|
-0.39 USD
|
174.359%
|
Itoco Inc.
|
-0.01 USD
|
3915.789%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
3000.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
11700.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
5278.571%
|
CytoDyn Inc.
|
-0.05 USD
|
648.204%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
58100.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
1406.306%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
100.189%
|
SYBLEU INC
|
-0.02 USD
|
1757.143%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
2142.254%
|
International Stem Cell Corporation
|
-0.02 USD
|
1868.293%
|
Bioxytran, Inc.
|
-0.03 USD
|
1009.091%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
290100.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
103.63%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
124.576%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
-0.03 USD
|
952.941%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
4703.175%
|
Neutra Corp.
|
-0.00 USD
|
290100.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
100.308%
|
PureTech Health plc
|
-2.38 USD
|
112.185%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
134.94%
|
IXICO plc
|
-0.02 USD
|
1288.525%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
610.563%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
121.481%
|
CSL Limited
|
5.47 USD
|
94.698%
|
Cellectis S.A.
|
-1.77 USD
|
116.384%
|